IllumiSonics
An independent, research-based, Canadian company producing innovative optical-, ultrasonic- and nano-technologies for medical and industrial applications.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
illumiSonics Inc. is a pioneering company in the medical imaging sector, specializing in advanced imaging solutions for real-time virtual histopathology. The company serves healthcare providers, particularly dermatologists and surgeons, by offering innovative imaging technologies that simplify and streamline procedures like Mohs surgery. Operating in the medical technology market, illumiSonics employs a B2B business model, generating revenue through the sale and licensing of its proprietary imaging systems. The company leverages its expertise in photoacoustic remote sensing (PARS) to provide non-radiative, high-contrast imaging from a single unstained slide, enabling the detection of temperature and pressure changes close to the source. This technology significantly enhances the accuracy and efficiency of surgical procedures, allowing healthcare professionals to treat more patients effectively. The company is led by experienced executives with a track record of driving growth and commercialization in both large corporations and startups. illumiSonics is headquartered in Waterloo, Ontario, Canada, and is poised to bring its cancer-detecting system to market within the next two years.
Keywords: medical imaging, virtual histopathology, Mohs surgery, PARS technology, non-radiative imaging, healthcare providers, dermatologists, surgeons, B2B model, cancer detection.